Venous Stent B.V. at CIRSE 2025

29 August 2025

Chief Executive Officer Darren Spencer will represent the company at the upcoming CIRSE 2025 Annual Congress in Barcelona.

Venous Stent B.V., a Netherlands-based medtech company developing next-generation venous stent technology, today announced that Chief Executive Officer Darren Spencer will represent the company at the upcoming CIRSE 2025 Annual Congress in Barcelona.

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress is the world’s leading event for interventional radiology, attracting thousands of physicians, researchers, and industry experts to exchange knowledge on the latest advances in minimally invasive therapies. Spencer will highlight Venous Stent’s innovative iliac venous stent platform, engineered to address the complex anatomical challenges of deep venous disease and improve long-term patient outcomes.

“CIRSE provides an unparalleled forum to showcase our technology to the interventional community,” said Darren Spencer, CEO of Venous Stent B.V. “We look forward to sharing our progress as we advance toward first-in-human studies and to building collaborations that will accelerate our mission of transforming venous care.”

Venous Stent B.V. remains focused on clinical development and regulatory milestones, with the aim of delivering a new standard of care in venous stenting.